Building on the resounding success of the last 9 North American Vaccine Forums, the 2012 event will once again provide a highly valuable meeting place for senior level industry and public sector figures driving the development of novel prophylactic and therapeutic vaccines.
The Phacilitate Vaccine Forum Washington 2012 is all about innovation. Find out how your competitors are optimizing the “4 Ds” of vaccine innovation:
• Smarter Design
• Leaner Development
• Novel Delivery
• Understanding Demand
And use this opportunity to benchmark your R&D progress, and build crucial relationships with companies, NGOs, key government figures, and the finance community.
The 3 day conference program will feature a mixture of business, regulatory and scientific topics, with speakers drawn from big pharma/biotech, the regulators and and vaccine developers themselves. Breakout sessions, workshops and panel discussions combine to make the event highly interactive.
In 2012, the Washington Vaccine Forum will once again run concurrently with Phacilitate’s annual North American Cell & Gene Therapy Forum, as well as the inaugural Protein Therapeutics Forum.. This year, for the first time, participants can attend any session in any program. All networking opportunities shared between the two events. Breakfast and lunch buffets, extended refreshment breaks and evening receptions will all take place in the shared exhibition area.
Conference Hound